Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

T. Iwasa, I. Okamoto, K. Takezawa, K. Yamanaka, T. Nakahara, A. Kita, H. Koutoku, M. Sasamata, E. Hatashita, Y. Yamada, K. Kuwata, M. Fukuoka, K. Nakagawa

Research output: Contribution to journalArticlepeer-review

57 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences